University at Buffalo

Behavioral Medicine Clinic



Cognitive Behavioral Therapy May Bring Rapid Relief to a Significant Number of Patients With Irritable Bowel Syndrome

5/5/2010 – Nearly 30% of patients with irritable bowel syndrome (IBS) reported considerable relief after 4 weeks of cognitive behavioral therapy (CBT), and the vast majority sustained these improvements for 3 months, according to a study published in the May issue of Clinical Gastroenterology and Hepatology.

Novel IBS Treatment Developed at UB Garners $8.5 Million for Seven–Year Clinical Trial

11/13/08 – Based on a successful pilot study of a primarily at–home, self–administered cognitive behavior therapy program, a University at Buffalo (UB) behavioral scientist has received $8.5 million from the National Institute of Diabetes, Digestive, and Kidney Diseases (NIDDK) to conduct a seven–year, multi–site clinical trial of an at–home program developed at UB to treat the symptoms of irritable bowel syndrome.

Home–Based Cognitive Behavioral Therapy Relieves IBS Symptoms

06/25/08 – Persons with irritable bowel syndrome (IBS) can relieve their symptoms as effectively by following a self–administered, at–home cognitive behavioral program as they can by undergoing a 10–week in–office program administered by a trained therapist, a new pilot study has shown.

NIH Panel Encourages Wider Acceptance of Behavioral Treatments For Chronic Pain and Insomnia

10/18/95 – An independent panel convened by the National Institutes of Health today encouraged wider acceptance of behavioral and relaxation therapies for treating chronic pain and insomnia and emphasized the need for broader use of these therapies in conjunction with conventional medical care of these disorders.

Behavioral Pain Control Treatments Are Effective

A new government sponsored systematic review of outpatient services for chronic pain control has found wide disparity in the effectiveness of current practice in Britain. Injections of corticosteroids in or around the shoulder joint for shoulder pain, and intravenous regional sympathetic blockade were found to be ineffective, according to the Health Technology Assessment report produced as part of the NHS research and development strategy. The report also found that cognitive behavioral therapies were effective across a range of pain problems.